Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant

Laura Vinué, Mohamad R. A. Sater, Ian Herriott, Miriam H. Huntley, George A. Jacoby, David C. Hooper
Laura Vinué
aMassachusetts General Hospital, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamad R. A. Sater
bDay Zero Diagnostics, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Herriott
bDay Zero Diagnostics, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam H. Huntley
bDay Zero Diagnostics, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George A. Jacoby
cLahey Hospital and Medical Center, Burlington, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Hooper
aMassachusetts General Hospital, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.00718-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

In a previous study, mutants with enhanced ciprofloxacin resistance (Cipr) were selected from Escherichia coli J53/pMG252 carrying qnrA1. Strain J53 Cipr 8-2 showed an increase in the copy number and transcription level of qnrA1. We sequenced the plasmids on Illumina and MinION platforms. Parental plasmid pMG252 and plasmid pMG252A from strain J53 Cipr 8-2 were almost identical, except for the region containing qnrA1 that in pMG252A contained 4 additional copies of the qnrA1-qacEΔ1-sul1-ISCR1 region.

TEXT

The plasmid-mediated quinolone resistance gene qnrA1 causes a modest decrease in quinolone susceptibility but facilitates the selection of mutants with higher levels of quinolone resistance through additional chromosomally encoded mechanisms (1, 2). Since the report of the first plasmid-mediated quinolone resistance (PMQR) determinant, qnrA1, in 1998, PMQR genes have been identified worldwide (3, 4).

In our previous study, in which mutants with decreased ciprofloxacin susceptibility were selected from J53/pMG252 with qnrA1 (1), we found that qnrA expression was 2.2-fold higher in mutant J53 Cipr (ciprofloxaxin resistance) 8-2 carrying what we term plasmid pMG252A than in the parental strain, with no changes detected in the qnrA promoter region. This mutant also had a 3.1-fold increase in qnrA copy number without a change in copy number for blaFOX-5, another marker on the plasmid, indicating that the qnrA copy number increase was gene specific and potentially responsible for increasing the ciprofloxacin MIC from 0.25 μg/ml in the parental strain to 2 μg/ml in the mutant. Furthermore, no mutations enhancing ciprofloxacin resistance were found in chromosomal genes of mutant J53 Cipr 8-2, and the enhanced resistance could be transferred by conjugation and eliminated along with pMG252A, indicating that plasmid pMG252A was directly involved.

Therefore, to confirm an increase in the number of copies of qnrA1 and the nature of the duplication, we sequenced both pMG252 and pMG252A from the J53 Cipr 8-2 mutant.

In a first attempt, we extracted both plasmids using the Qiagen large construct kit and obtained some short-read sequences with the Illumina platform, performed by the Center for Computational and Integrative Biology (CCIB) DNA Core Facility at Massachusetts General Hospital (Cambridge, MA). Libraries were pooled in equimolar concentrations for multiplexed sequencing on the Illumina MiSeq platform with a 2 × 150-bp read run parameter. Purified plasmids were sequenced, producing 154 × 105 reads and 1.28 × 105 reads for plasmids pMG252 and pMG252A, respectively. Ninety-five percent of the reads had a mean sequence quality (Phred score) of >30. The total depth of coverage after deduplication for each plasmid was 108× for pMG252 and 98× for pMG252A. Because of the large size of pMG252 (∼180 kb) (2) and the challenges imposed by insertion elements, repetitive sequences, and duplications, de novo assembly from these data was unable to produce a circularized plasmid sequence or an unambiguous location and copy number for qnrA1. To overcome these challenges, we used the MinION platform (Oxford Nanopore Technologies) to produce long sequence reads via Day Zero Diagnostics (Boston, MA). Total DNA was extracted using the Genomic DNA kit (Genomic-tip 100/G; Qiagen), prepped with SQK-RBK004, run using an R9.4.1 flow cell on a MinION Mk1B sequencer controlled by MinKNOW 2.0, and base called using Albacore v2.3.1. A larger number of reads and higher read lengths were achieved, and circularized plasmids were obtained. The final assembly was polished using Illumina reads (Fig. 1).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Genetic map of parental pMG252 plasmid. The figure was constructed with Geneious Prime 2019.0.4.

The circularized sequence of plasmid pMG252 was 185,643 bp long, while that of pMG252A was 201,521 bp. The two plasmids had the common backbone of IncA/C plasmids (5, 6). They were identified as IncA/C2 type 2 (5). Additionally, plasmid MLST (PMLST) typing assigned the pMG252 plasmid to sequence type 3 (ST3), which is the most common group of IncA/C plasmids (6). By the core gene PMLST (cgPMLST) scheme (7), pMG252 belongs to core-genome ST 3.3 (cgST3.3).

pMG252, which is the first plasmid identified with a qnr gene, was found in a Klebsiella pneumoniae clinical isolate (8). It had an average G+C content of 52.8%. It contained a large antibiotic resistance island (41,056 bp) located between the two ends of the rhs2 gene. This module included a class 1 integron (termed region S1) with the following gene cassette array: blaCARB-2-aadA2-cmlA1-catB11-qacEΔ1-sul1-ISCR1-qnrA1-qacEΔ1-sul1-ISCR1-dfrA19, followed by another class 1 integron harboring an aadB-catB3 array. Downstream from the integrons were msr(E), encoding a macrolide efflux pump, and mph(E), encoding a macrolide 2′-phosphotransferase, both associated with insertion sequence IS26. Different insertion sequences separated the msr(E)-mph(E) module from a mercury resistance operon that was bracketed by the end of the rhs2 gene (Fig. 1).

Other plasmid-encoded functions that have been previously annotated in sequenced IncA/C2 plasmids (5) have been also identified in pMG252 (Fig. 1). These functions included genes for methyltransferases (dcm1, dcm2, and dcm3), DNA metabolism (nuc, topB, kfrA, uvrD, ter, int, and pri), protein export and folding (sppA, dsbA, dsbC, and yacC), and plasmid stability (parA-parB and stbA) (Fig. 1).

In a comparison of the assemblies of pMG252 and pMG252A, they were found to be 88.9% identical, which was ascertained using the multiple-sequence alignment program MAFFT (Geneious). The major difference between them was in region S1 that indeed contained multiple copies of qnrA1 (Fig. 2). In most qnrA1-containing plasmids, a single copy of ISCR1 is found downstream from qnrA1, but in plasmid pMG252, qnrA1 is surrounded by two copies of ISCR1. The qnrA1-ISCR1 complex is inserted into sul1-type integron-containing cassettes that confer resistance to β-lactams (blaCARB-2), chloramphenicol (cmlA1 and catB11), streptomycin (aadA2), sulfonamide (sul1), and trimethoprim (dfrA19) (2). The assembled sequence of plasmid pMG252A revealed the presence of four additional copies of qnrA1-qacEΔ1-sul1-ISCR1, thus validating our findings of an increased qnrA1 copy number.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

(A and B) Genetic environment of qnrA1 in plasmids pMG252 (A) and pMG252A (B) in region S1. Purple arrows show genes conferring resistance to antimicrobials or biocides, dotted purple arrows indicate the multiple copies of qnrA1, and green arrows denote elements involved in recombination and/or transposition.

There are numerous studies describing the prevalence of PMQR harboring qnrA1 in Enterobacteriaceae (9, 10). qnrA1 has been associated in the same plasmid with other PMQR genes, such as qnrB, qnrS, and qepA (11), but it is unusual to find more than one copy of the same PMQR gene within a plasmid. An exception is plasmid pSZ50 from Mexico, in which the entire integron containing ISCR1, qnrA1, and other resistance genes was duplicated in tandem, although quinolone resistance was not increased (12). In our study, plasmid pMG252A with 5 copies of qnrA1 had an 8-fold higher MIC to ciprofloxacin than did its pMG252 parent, reaching an MIC of 2 μg/ml ciprofloxacin and thus exceeding the CLSI breakpoint for resistance (13). The elevated resistance was transmissible by pMG252A on conjugation. Unlike other qnr types, qnrA1 is not inducible by quinolones (14). The duplication of ISCR1 around qnrA1 in pMG252 and related plasmids creates the structure of a composite transposon; this facilitates enhancement of the qnrA1 copy number and, consequently, quinolone resistance under conditions of quinolone stress, and it adds to the repertoire of mechanisms that can increase quinolone resistance to clinically important levels.

The genetic organization of blaFOX-5 in pMG252 was similar to that previously published (GenBank accession number CP007732). Upstream of the blaFOX-5 gene, there was a region with 98% DNA homology to the ISAs2 transposase gene from Aeromonas salmonicida, a member of the IS30 family (15), followed by a bleomycin resistance gene. Immediately in the 3′ direction, there was a multidrug transporter gene (mdrL), followed by a transcriptional regulator gene (lysR) and another copy of ISAs2.

In summary, we determined by plasmid sequencing the novel presence of 5 copies of qnrA1 in plasmid pMG252A, as a result of transposition via insertion sequence ISCR1 located downstream from qnrA1 within a class 1 integron; we also characterized pMG252 as a sequence type 3.3 (ST3.3) member of the IncA/C2 type 2 family.

Data availability.The sequences of the entire plasmids pMG252 and pMG252A have been deposited in the NCBI GenBank database under accession numbers MK638972 and MK733575, respectively.

ACKNOWLEDGMENT

This work was supported by grant R01 AI057576 (to D.C.H.) from the National Institutes of Health, U.S. Public Health Service.

FOOTNOTES

    • Received 3 April 2019.
    • Returned for modification 1 May 2019.
    • Accepted 23 May 2019.
    • Accepted manuscript posted online 3 June 2019.
  • Copyright © 2019 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Vinué L,
    2. Corcoran MA,
    3. Hooper DC,
    4. Jacoby GA
    . 2015. Mutations that enhance the ciprofloxacin resistance of Escherichia coli with qnrA1. Antimicrob Agents Chemother 60:1537–1545. doi:10.1128/AAC.02167-15.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Strahilevitz J,
    2. Jacoby GA,
    3. Hooper DC,
    4. Robicsek A
    . 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22:664–689. doi:10.1128/CMR.00016-09.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Poirel L,
    2. Madec JY,
    3. Lupo A,
    4. Schink AK,
    5. Kieffer N,
    6. Nordmann P,
    7. Schwarz S
    . 2018. Antimicrobial resistance in Escherichia coli. Microbiol Spectr 22:ARB-0026-2017. doi:10.1128/microbiolspec.ARBA-0026-2017.
    OpenUrlCrossRef
  4. 4.↵
    1. Jacoby GA,
    2. Strahilevitz J,
    3. Hooper DC
    . 2014. Plasmid mediated quinolone resistance. Microbiol Spectr 2:PLAS-0006-2013. doi:10.1128/microbiolspec.PLAS-0006-2013.
    OpenUrlCrossRef
  5. 5.↵
    1. Harmer CJ,
    2. Hall RM
    . 2015. The A to Z of A/C plasmids. Plasmid 80:63–82. doi:10.1016/j.plasmid.2015.04.003.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Hancock SJ,
    2. Phan MD,
    3. Peters KM,
    4. Forde BM,
    5. Chong TM,
    6. Yin WF,
    7. Chan KG,
    8. Paterson DL,
    9. Walsh TR,
    10. Beatson SA,
    11. Schembri MA
    . 2017. Identification of IncA/C plasmid replication and maintenance genes and development of a plasmid multilocus sequence typing scheme. Antimicrob Agents Chemother 61:e01740-16. doi:10.1128/AAC.01740-16.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Jolley KA,
    2. Maiden MC
    . 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. doi:10.1186/1471-2105-11-595.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Martínez-Martínez L,
    2. Pascual A,
    3. Jacoby GA
    . 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797–799. doi:10.1016/S0140-6736(97)07322-4.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Robicsek A,
    2. Strahilevitz J,
    3. Sahm DF,
    4. Jacoby GA,
    5. Hooper DC
    . 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50:2872–2874. doi:10.1128/AAC.01647-05.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Szabó O,
    2. Gulyás D,
    3. Szabó N,
    4. Kristóf K,
    5. Kocsis B,
    6. Szabó D
    . 2018. Plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from urine clinical samples. Acta Microbiol Immunol Hung 65:255–265. doi:10.1556/030.65.2018.012.
    OpenUrlCrossRef
  11. 11.↵
    1. Abd El-Aziz NK,
    2. Gharib AA
    . 2015. Coexistence of plasmid-mediated quinolone resistance determinants and AmpC-beta-lactamases in Escherichia coli strains in Egypt. Cell Mol Biol (Noisy-le-grand) 61:29–35.
    OpenUrl
  12. 12.↵
    1. Garza-Ramos U,
    2. Barrios H,
    3. Hernandez-Vargas MJ,
    4. Rojas-Moreno T,
    5. Reyna-Flores F,
    6. Tinoco P,
    7. Othon V,
    8. Poirel L,
    9. Nordmann P,
    10. Cattoir V,
    11. Ruiz-Palacios G,
    12. Fernandez JL,
    13. Santamaria RI,
    14. Bustos P,
    15. Castro N,
    16. Silva-Sanchez J
    . 2012. Transfer of quinolone resistance gene qnrA1 to Escherichia coli through a 50 kb conjugative plasmid resulting from the splitting of a 300 kb plasmid. J Antimicrob Chemother 67:1627–1634. doi:10.1093/jac/dks123.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Clinical and Laboratory Standards Institute. 2019. Fluoroquinolone breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa, 1st ed. CLSI document MR02. Clinical and Laboratory Standards Institute, Wayne, PA.
  14. 14.↵
    1. Kim HB,
    2. Park CH,
    3. Gavin M,
    4. Jacoby GA,
    5. Hooper DC
    . 2011. Cold shock induces qnrA expression in Shewanella algae. Antimicrob Agents Chemother 55:414–416. doi:10.1128/AAC.00991-10.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Queenan AM,
    2. Jenkins S,
    3. Bush K
    . 2001. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded β-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother 45:3189–3194. doi:10.1128/AAC.45.11.3189-3194.2001.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant
Laura Vinué, Mohamad R. A. Sater, Ian Herriott, Miriam H. Huntley, George A. Jacoby, David C. Hooper
Antimicrobial Agents and Chemotherapy Jul 2019, 63 (8) e00718-19; DOI: 10.1128/AAC.00718-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant
Laura Vinué, Mohamad R. A. Sater, Ian Herriott, Miriam H. Huntley, George A. Jacoby, David C. Hooper
Antimicrobial Agents and Chemotherapy Jul 2019, 63 (8) e00718-19; DOI: 10.1128/AAC.00718-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

A/C2 plasmid
Escherichia coli
ISCR1
ciprofloxacin
qnrA1

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596